Rational Tuning of CAR Tonic Signaling Yields Superior T-Cell Therapy for Cancer
Chen, X.; Khericha, M.; Lakhani, A.; Meng, X.; Salvestrini, E.; Chen, L. C.; Shafer, A.; Alag, A.; Ding, Y.; Nicolaou, D.; Park, J. O.; Chen, Y. Y.
Show abstract
Chimeric antigen receptors (CARs) are modular proteins capable of redirecting immune cells toward a wide variety of disease-associated antigens. Here, we explore the effects of CAR protein sequence and structure on CAR-T cell function. Based on the empirical observation that CD20 CARs with similar sequences exhibit divergent tonic-signaling and anti-tumor activities, we devised engineering strategies that aimed to improve CAR-T cell function by tuning the intensity of tonic signaling. We found that CARs designed to exhibit low but non-zero levels of tonic signaling show robust effector function upon antigen stimulation while avoiding premature functional exhaustion by CAR-T cells. Through alterations of the CARs ligand-binding domain and overall protein conformation, we generated CD20 CAR variants that outperform the CD19 CAR in mouse models of human lymphoma. We further demonstrate that rational modification of protein confirmation can be generalized to improve GD2 CAR-T cell efficacy against neuroblastoma. These findings point to tonic signaling and basal T-cell activation as informative parameters to guide the rational design of next-generation CARs for cancer therapy.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- TET2 regulates early and late transitions in exhausted CD8+ T-cell differentiation and limits CAR T-cell function 97%
- A new universal chimeric-antigen receptor (CAR)- fragment antibody binder (FAB) split system for cancer immunotherapy 97%
- Integrating Single-Cell Biophysical and Transcriptomic Features to Resolve Functional Heterogeneity in Mantle Cell Lymphoma 96%
Similar papers in this journal
- Neoantigen Cancer Vaccines and Different Immune Checkpoint Therapies Each Utilize Both Converging and Distinct Mechanisms that in Combination Enable Synergistic Therapeutic Efficacy 97%
- Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment 97%
- An autophagy program that promotes T cell egress from the lymph node controls responses to immune checkpoint blockade 95%
Similar papers in this journal
- Oxygen levels at the time of activation determine T cell persistence and immunotherapeutic efficacy 96%
- T cell receptor convergence is an indicator of antigen-specific T cell response in cancer immunotherapies 95%
- Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases 95%
Similar papers in this journal
- Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor resistant HER2-positive breast cancer 96%
- Semaphorin 3A induces cytoskeletal paralysis in tumor-specific CD8+ T cells 96%
- Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting 96%
Similar papers in this journal
- Collagen-binding IL-12 expressing STEAP1 CAR-T cells reduce toxicity and eradicate mouse prostate cancer in combination with checkpoint inhibitors 97%
- In vivo affinity maturation of the HIV-1 Env-binding domain of CD4 96%
- Generation of T cells with reduced off-target cross-reactivities by engineering co-signalling receptors 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.